Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CompuMed Inc. (CMPD : OTCBB)

• Company Description    COMPUMED, INC. is a medical systems company engaged primarily in the application of computer technology to medicine. The main aspects of Co.'s business are (i) the licensing of its proprietary technology in the OsteoGramR, a bone density test that was developed by the Company as a means of aiding physicians in diagnosing and monitoring osteoporosis, (ii) the computer interpretation of electrocardiograms, (iii) TeleCor Services Division, which is engaged in transtelephonic cardiac event monitoring. Number of Employees: 8

• Price / Volume Information    Yesterday's Closing Price: $0.15 Daily Weekly Monthly 20 Day Moving Average: 35,177 shares Shares Outstanding: 42.29 (millions) Market Capitalization: $6.34 (millions) Beta: 1.44 52 Week High: $0.39 52 Week Low: $0.14 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -24.05% -14.47% 12 Week -52.96% -48.29% Year To Date -48.28% -28.37%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5777 West Century Blvd. Suite 360 - Los Angeles,CA 90045 USA ph: 310-258-5000 fax: 310-645-5880 investorrelations@compumedinc.com http://www.compumedinc.com

• General Corporate Information    Officers Lee Keddie - Chief Executive Officer; President and Director David W. Pointer - Chairman of the Board Laura Carroll - Chief Financial Officer and Corporate Secretary Loren Den Herder - Director Charles Gillman - Director Peer Information CompuMed Inc. (BJCT) CompuMed Inc. (CADMQ) CompuMed Inc. (APNO) CompuMed Inc. (UPDC) CompuMed Inc. (IMTIQ) CompuMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 204914402 SIC: 7374 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/15/22 Share - Related Items Shares Outstanding: 42.29 Most Recent Split Date: 10.00 (0.10:1) Beta: 1.44 Market Capitalization: $6.34 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/15/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 7.50 PEG Ratio: - Price Ratios Price/Book: 1.82 Price/Cash Flow: 4.31 Price / Sales: 1.00 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -1.90% vs. Previous Quarter: 3.90% ROE 03/31/22 - 27.66 12/31/21 - 32.70 09/30/21 - 37.49 ROA 03/31/22 - 17.49 12/31/21 - 20.35 09/30/21 - 23.10 Current Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - 2.70 Quick Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - 2.58 Operating Margin 03/31/22 - 13.58 12/31/21 - 15.16 09/30/21 - 16.87 Net Margin 03/31/22 - 13.60 12/31/21 - 15.18 09/30/21 - 16.87 Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - 16.94 Book Value 03/31/22 - - 12/31/21 - - 09/30/21 - 0.08 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - 20.92 Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - 0.16 Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - 13.80

Powered by Zacks Investment Research ©